1.
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
by Scheen, André J
The Lancet (British edition), 2006, Vol.368 (9548), p.1660-1672
2.
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
by Esser, Nathalie
Diabetologia, 2019-05-14, Vol.62 (7), p.1113-1122
3.
4.
Effects of Growth Hormone (GH) on Ghrelin, Leptin, and Adiponectin in GH-Deficient Patients
by Engström, Britt Edén
The journal of clinical endocrinology and metabolism, 2003-11, Vol.88 (11), p.5193-5198
5.
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
by Lavalle-González, F. J
Diabetologia, 2013-09-13, Vol.56 (12), p.2582-2592
6.
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
by Shin, Na-Ri
Gut, 2014-05, Vol.63 (5), p.727-735
7.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
by le Roux, Carel W, Prof
The Lancet (British edition), 2017, Vol.389 (10077), p.1399-1409
8.
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
by Fleseriu, Maria
The journal of clinical endocrinology and metabolism, 2012-06, Vol.97 (6), p.2039-2049
9.
SGLT2 Inhibitors May Predispose to Ketoacidosis
by Taylor, Simeon I
The journal of clinical endocrinology and metabolism, 2015-08, Vol.100 (8), p.2849-2852
10.
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
by Plovier, Hubert
Nature medicine, 2017, Vol.23 (1), p.107-113
11.
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
by Buse, John B, Prof
The Lancet (British edition), 2009, Vol.374 (9683), p.39-47
12.
Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice
by Lee, Jaemin
Nature medicine, 2016-09, Vol.22 (9), p.1023-1032
13.
Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats
by SOPASAKIS, V. Rotter
Diabetologia, 2004, Vol.47 (11), p.1879-1887
14.
The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
by Cherney, David
Diabetologia, 2016-06-17, Vol.59 (9), p.1860-1870
15.
Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT ra...
by Oskarsson, Per
Diabetologia, 2017-12-23, Vol.61 (3), p.539-550
16.
Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents
by Scarlett, Jarrad M
Nature medicine, 2016-07, Vol.22 (7), p.800-806
17.
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
by Scaroni, Carla
Endocrine reviews, 2017-06-01, Vol.38 (3), p.189-219
18.
Coming of age: the artificial pancreas for type 1 diabetes
by Thabit, Hood
Diabetologia, 2016-06-30, Vol.59 (9), p.1795-1805
19.
TRPM3 Is a Nociceptor Channel Involved in the Detection of Noxious Heat
by Vriens, Joris
Neuron (Cambridge, Mass.), 2011, Vol.70 (3), p.482-494
20.
Placental endoplasmic reticulum stress in gestational diabetes: the potential for therapeutic intervention with chemical chaperones and antioxidants
by Yung, Hong-wa
Diabetologia, 2016-07-12, Vol.59 (10), p.2240-2250
